NVCR logo

NovoCure Limited (NVCR) Selling, general & administrative expenses

annual SGA:

$428.89M+$38.02M(+9.73%)
December 31, 2024

Summary

  • As of today (May 29, 2025), NVCR annual SGA is $428.89 million, with the most recent change of +$38.02 million (+9.73%) on December 31, 2024.
  • During the last 3 years, NVCR annual SGA has risen by +$165.71 million (+62.96%).
  • NVCR annual SGA is now at all-time high.

Performance

NVCR SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNVCRincome statement metrics

quarterly SGA:

$100.56M-$39.33M(-28.12%)
March 31, 2025

Summary

  • As of today (May 29, 2025), NVCR quarterly SGA is $100.56 million, with the most recent change of -$39.33 million (-28.12%) on March 31, 2025.
  • Over the past year, NVCR quarterly SGA has increased by +$5.83 million (+6.15%).
  • NVCR quarterly SGA is now -28.12% below its all-time high of $139.89 million, reached on December 31, 2024.

Performance

NVCR quarterly SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNVCRincome statement metrics

TTM SGA:

-$4.49B-$164.19M(-3.80%)
March 31, 2025

Summary

  • As of today (May 29, 2025), NVCR TTM SGA is -$4.49 billion, with the most recent change of -$164.19 million (-3.80%) on March 31, 2025.
  • Over the past year, NVCR TTM SGA has dropped by -$4.88 billion (-1243.58%).
  • NVCR TTM SGA is now -1523.30% below its all-time high of -$276.50 million.

Performance

NVCR TTM SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNVCRincome statement metrics

Selling, general & administrative expenses Formula

SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development

NVCR Selling, general & administrative expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+9.7%+6.2%-1243.6%
3 y3 years+63.0%+47.0%-1768.0%
5 y5 years+132.3%+81.4%-2372.7%

NVCR Selling, general & administrative expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+63.0%-28.1%+47.0%-67.3%at low
5 y5-yearat high+132.3%-28.1%+86.7%-76.4%at low
alltimeall timeat high+1199.3%-28.1%+865.4%-1523.3%at low

NVCR Selling, general & administrative expenses History

DateAnnualQuarterlyTTM
Mar 2025
-
$100.56M(-28.1%)
$434.71M(+1.4%)
Dec 2024
$428.89M(+9.7%)
$139.89M(+40.0%)
$428.89M(+10.6%)
Sep 2024
-
$99.93M(+5.9%)
$387.63M(+0.0%)
Jun 2024
-
$94.33M(-0.4%)
$387.55M(-1.3%)
Mar 2024
-
$94.74M(-4.0%)
$392.49M(+0.4%)
Dec 2023
$390.87M(+27.6%)
$98.64M(-1.2%)
$390.87M(+2.9%)
Sep 2023
-
$99.85M(+0.6%)
$379.93M(+7.3%)
Jun 2023
-
$99.27M(+6.6%)
$353.98M(+6.9%)
Mar 2023
-
$93.11M(+6.2%)
$331.13M(+8.1%)
Dec 2022
$306.41M(+16.4%)
$87.70M(+18.7%)
$306.41M(+6.1%)
Sep 2022
-
$73.90M(-3.3%)
$288.70M(+3.6%)
Jun 2022
-
$76.42M(+11.7%)
$278.61M(+3.5%)
Mar 2022
-
$68.39M(-2.3%)
$269.09M(+2.2%)
Dec 2021
$263.18M(+16.7%)
$69.99M(+9.7%)
$263.18M(+4.1%)
Sep 2021
-
$63.81M(-4.6%)
$252.91M(+3.0%)
Jun 2021
-
$66.90M(+7.1%)
$245.53M(+5.6%)
Mar 2021
-
$62.48M(+4.6%)
$232.50M(+3.1%)
Dec 2020
$225.45M(+22.1%)
$59.72M(+5.8%)
$225.46M(+4.2%)
Sep 2020
-
$56.42M(+4.8%)
$216.29M(+4.8%)
Jun 2020
-
$53.87M(-2.8%)
$206.40M(+4.5%)
Mar 2020
-
$55.44M(+9.7%)
$197.49M(+7.0%)
Dec 2019
$184.62M
$50.55M(+8.6%)
$184.62M(+5.9%)
DateAnnualQuarterlyTTM
Sep 2019
-
$46.54M(+3.5%)
$174.34M(+5.2%)
Jun 2019
-
$44.96M(+5.6%)
$165.78M(+4.8%)
Mar 2019
-
$42.57M(+5.7%)
$158.23M(+4.7%)
Dec 2018
$151.12M(+23.2%)
$40.28M(+6.0%)
$151.12M(+5.4%)
Sep 2018
-
$37.98M(+1.5%)
$143.32M(+4.7%)
Jun 2018
-
$37.40M(+5.5%)
$136.94M(+4.6%)
Mar 2018
-
$35.46M(+9.2%)
$130.92M(+6.8%)
Dec 2017
$122.64M(+11.0%)
$32.48M(+2.8%)
$122.64M(+3.2%)
Sep 2017
-
$31.60M(+0.7%)
$118.84M(+2.6%)
Jun 2017
-
$31.38M(+15.5%)
$115.82M(+3.3%)
Mar 2017
-
$27.18M(-5.2%)
$112.07M(+1.5%)
Dec 2016
$110.46M(+51.9%)
$28.68M(+0.3%)
$110.46M(+2.6%)
Sep 2016
-
$28.59M(+3.5%)
$107.62M(+11.7%)
Jun 2016
-
$27.63M(+8.1%)
$96.35M(+13.4%)
Mar 2016
-
$25.56M(-1.1%)
$84.96M(+16.8%)
Dec 2015
$72.72M(+60.8%)
$25.84M(+49.2%)
$72.72M(+21.5%)
Sep 2015
-
$17.32M(+6.7%)
$59.88M(+13.0%)
Jun 2015
-
$16.23M(+21.8%)
$52.97M(+44.2%)
Mar 2015
-
$13.33M(+2.6%)
$36.74M(+56.9%)
Dec 2014
$45.23M(+37.0%)
$12.99M(+24.7%)
$23.41M(+124.7%)
Sep 2014
-
$10.42M
$10.42M
Dec 2013
$33.01M
-
-

FAQ

  • What is NovoCure Limited annual SGA?
  • What is the all time high annual SGA for NovoCure Limited?
  • What is NovoCure Limited annual SGA year-on-year change?
  • What is NovoCure Limited quarterly SGA?
  • What is the all time high quarterly SGA for NovoCure Limited?
  • What is NovoCure Limited quarterly SGA year-on-year change?
  • What is NovoCure Limited TTM SGA?
  • What is the all time high TTM SGA for NovoCure Limited?
  • What is NovoCure Limited TTM SGA year-on-year change?

What is NovoCure Limited annual SGA?

The current annual SGA of NVCR is $428.89M

What is the all time high annual SGA for NovoCure Limited?

NovoCure Limited all-time high annual SGA is $428.89M

What is NovoCure Limited annual SGA year-on-year change?

Over the past year, NVCR annual SGA has changed by +$38.02M (+9.73%)

What is NovoCure Limited quarterly SGA?

The current quarterly SGA of NVCR is $100.56M

What is the all time high quarterly SGA for NovoCure Limited?

NovoCure Limited all-time high quarterly SGA is $139.89M

What is NovoCure Limited quarterly SGA year-on-year change?

Over the past year, NVCR quarterly SGA has changed by +$5.83M (+6.15%)

What is NovoCure Limited TTM SGA?

The current TTM SGA of NVCR is -$4.49B

What is the all time high TTM SGA for NovoCure Limited?

NovoCure Limited all-time high TTM SGA is -$276.50M

What is NovoCure Limited TTM SGA year-on-year change?

Over the past year, NVCR TTM SGA has changed by -$4.88B (-1243.58%)
On this page